Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256743474> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4256743474 endingPage "275" @default.
- W4256743474 startingPage "267" @default.
- W4256743474 abstract "Mineralocorticoid receptor (MR) blockade has proven efficacy in the treatment of hypertension and in improving morbidity and mortality in patients with heart failure. The potential importance of mineralocorticoid receptor blockade has grown recently amid the observation that angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers do not effectively reduce aldosterone levels in all patients over the long term. To date, research on the role of MR blockade has primarily focused on resistant hypertension, decreasing proteinuria, and potentially preventing disease progression in early stages of chronic kidney disease (CKD). Given the prevalence of co-morbid resistant hypertension and cardiovascular disease in patients with end-stage renal disease (ESRD), however, interest in the role of MR blockade in this patient population has arisen. In this paper, we review the current evidence for using MR blockade in mild-tomoderate and resistant hypertension in patients with normal renal function, CKD, and ESRD. We discuss recent animal and human studies on the role of aldosterone in mediating hypertension as well as vascular and tissue damage. We then review clinical studies on the use of MR blockade in ameliorating aldosterone’s deleterious end organ effects and its applicability to patients with ESRD. Finally, we summarize the evidence to date supporting the safety of MR blockade in patients with ESRD. Keywords: Aldosterone, end stage renal disease, end organ damage, hyperkalemia, mineralocorticoid receptor blockade, resistant hypertension" @default.
- W4256743474 created "2022-05-12" @default.
- W4256743474 creator A5020881383 @default.
- W4256743474 creator A5056413186 @default.
- W4256743474 date "2012-12-12" @default.
- W4256743474 modified "2023-09-24" @default.
- W4256743474 title "Mineralocorticoid Receptor-Associated Hypertension and Target Organ Damage: Clinical Relevance for Resistant Hypertension in End Stage Renal Disease" @default.
- W4256743474 doi "https://doi.org/10.2174/1573402111208040267" @default.
- W4256743474 hasPublicationYear "2012" @default.
- W4256743474 type Work @default.
- W4256743474 citedByCount "1" @default.
- W4256743474 countsByYear W42567434742018 @default.
- W4256743474 crossrefType "journal-article" @default.
- W4256743474 hasAuthorship W4256743474A5020881383 @default.
- W4256743474 hasAuthorship W4256743474A5056413186 @default.
- W4256743474 hasConcept C126322002 @default.
- W4256743474 hasConcept C134018914 @default.
- W4256743474 hasConcept C159641895 @default.
- W4256743474 hasConcept C164705383 @default.
- W4256743474 hasConcept C170493617 @default.
- W4256743474 hasConcept C189135053 @default.
- W4256743474 hasConcept C2776069600 @default.
- W4256743474 hasConcept C2778468042 @default.
- W4256743474 hasConcept C2778525890 @default.
- W4256743474 hasConcept C2778653478 @default.
- W4256743474 hasConcept C2779134260 @default.
- W4256743474 hasConcept C2780243291 @default.
- W4256743474 hasConcept C3019040382 @default.
- W4256743474 hasConcept C57190642 @default.
- W4256743474 hasConcept C71924100 @default.
- W4256743474 hasConcept C84393581 @default.
- W4256743474 hasConceptScore W4256743474C126322002 @default.
- W4256743474 hasConceptScore W4256743474C134018914 @default.
- W4256743474 hasConceptScore W4256743474C159641895 @default.
- W4256743474 hasConceptScore W4256743474C164705383 @default.
- W4256743474 hasConceptScore W4256743474C170493617 @default.
- W4256743474 hasConceptScore W4256743474C189135053 @default.
- W4256743474 hasConceptScore W4256743474C2776069600 @default.
- W4256743474 hasConceptScore W4256743474C2778468042 @default.
- W4256743474 hasConceptScore W4256743474C2778525890 @default.
- W4256743474 hasConceptScore W4256743474C2778653478 @default.
- W4256743474 hasConceptScore W4256743474C2779134260 @default.
- W4256743474 hasConceptScore W4256743474C2780243291 @default.
- W4256743474 hasConceptScore W4256743474C3019040382 @default.
- W4256743474 hasConceptScore W4256743474C57190642 @default.
- W4256743474 hasConceptScore W4256743474C71924100 @default.
- W4256743474 hasConceptScore W4256743474C84393581 @default.
- W4256743474 hasIssue "4" @default.
- W4256743474 hasLocation W42567434741 @default.
- W4256743474 hasOpenAccess W4256743474 @default.
- W4256743474 hasPrimaryLocation W42567434741 @default.
- W4256743474 hasRelatedWork W2023418293 @default.
- W4256743474 hasRelatedWork W2037408526 @default.
- W4256743474 hasRelatedWork W2069080293 @default.
- W4256743474 hasRelatedWork W2072829430 @default.
- W4256743474 hasRelatedWork W2168712739 @default.
- W4256743474 hasRelatedWork W2516746587 @default.
- W4256743474 hasRelatedWork W2530319271 @default.
- W4256743474 hasRelatedWork W2625684060 @default.
- W4256743474 hasRelatedWork W32200126 @default.
- W4256743474 hasRelatedWork W4232426836 @default.
- W4256743474 hasVolume "8" @default.
- W4256743474 isParatext "false" @default.
- W4256743474 isRetracted "false" @default.
- W4256743474 workType "article" @default.